Followers | 210 |
Posts | 11026 |
Boards Moderated | 1 |
Alias Born | 04/20/2011 |
Wednesday, August 10, 2016 8:04:12 PM
Industry has been awaiting decision on possible regulatory changes
A long-awaited decision that could determine the future of the U.S. marijuana industry is expected Thursday.
The Drug Enforcement Administration said late Wednesday that it would publish its response to a congressional petition to reschedule marijuana in the Federal Register on Thursday morning.
The announcement could have far-reaching implications for the industry, particularly if the agency chooses to change the way it regulates marijuana. Marijuana is currently filed under Schedule I, meaning it has a high potential for abuse and has no accepted medical value.
The DEA’s response could move the drug to a less-restrictive schedule, which would allow more research under continued regulation. It could also deschedule it, which would completely remove it from the agency’s regulation, or take no action. The DEA’s email didn't indicate which course the agency might select.
If marijuana were to be rescheduled, the current infrastructure within states that have legalized the drug for medical purposes could be completely changed. For the past 20 years, states that have legalized medical marijuana have done so outside the workings of the pharmaceutical industry, using doctor’s “recommendations” instead of prescriptions and providing it through dispensaries rather than pharmacies.
Rescheduling medical marijuana could mean it would be treated like Vicodin, OxyContin or Adderall and be subject to the standard prescription process.
http://www.marketwatch.com/story/dea-to-make-long-awaited-marijuana-announcement-thursday-2016-08-10
I am a trader, only a trader. my posts are my opinion and are
not for sale. I do my DD, I advise you to do yours. My posts
are not recommendations to buy or sell. I have never and
will not accept payment to post on any stock. So don't ask.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM